HTBX (HTBX) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 29 254 sessions, April 30, 2021 to May 2, 2022
- Largest daily move
- +40.1% close of June 10, 2021
- 1-year change
- -65.4% closing prices, April 30, 2021 to May 2, 2022
- 5-year change
- -95.6% closing prices, May 2, 2017 to May 2, 2022
Company Description
HTBX (AMEX: HTBX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $72.6M.
HTBX has declined 65.4% over the past year. The last closing price was $2.38.
This page collects what Stock Titan holds for HTBX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
HTBX (HTBX) closed at $2.38 on May 2, 2022. Over the past 12 months, the price has lost 65.4%.
HTBX Metrics & Rankings
Price returns through May 2, 2022. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
HTBX has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, conferences, acquisition. View all HTBX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
HTBX Company Profile & Sector Positioning
HTBX (HTBX) operates in the Biotechnology industry within the broader Healthcare sector.
Investors comparing HTBX often look at related companies in the same sector, including Cibus, Inc. (CBUS), Alterity Therapeutics Limited American (ATHE), Aligos Therapeutics, Inc. (ALGS), BeyondSpring Inc. (BYSI), and Context Therapeutics Inc. (CNTX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate HTBX's relative position within its industry.